SCHEMBL2045441

SCHEMBL2045441

ON=C(Cl)c1cccc(-n2cncn2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.44
CHRNA7 P36544 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.37
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
GRK6 P43250 1/20 0.37
MGLL Q99685 1/20 0.36
RAB9A P51151 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
BRD4 O60885 1/20 0.33
CREBBP Q92793 1/20 0.33
TP53 P04637 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
S1PR1 P21453 2/20 0.32
S1PR3 Q99500 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4459474 0.81 SMN1; SMN2 (0.49) CYP2A6SMN1; SMN2ALDH1A1KDM4ERAB9A
SCHEMBL1613623 0.77 S1PR3 (0.47) ALDH1A1KDM4ERAB9AMEN1KMT2A
SCHEMBL1613624 0.77 S1PR3 (0.47) ALDH1A1KDM4ERAB9AMEN1KMT2A
SCHEMBL6759842 0.77 CYP2A6 (0.47) CYP2A6CHRNA7SMN1; SMN2ALDH1A1KDM4E
SCHEMBL29449994 0.77 MAOA (0.49) CYP2A6SMN1; SMN2ALDH1A1KDM4EGRK6
SCHEMBL940731 0.77 MAOA (0.49) CYP2A6SMN1; SMN2ALDH1A1KDM4EGRK6
SCHEMBL11926858 0.77 CYP2A6 (0.62) CYP2A6CHRNA7SMN1; SMN2ALDH1A1KDM4E
SCHEMBL1612258 0.74 CYP1A2 (0.40) ALDH1A1RAB9ARXFP1MEN1KMT2A
SCHEMBL1612257 0.74 CYP1A2 (0.40) ALDH1A1RAB9ARXFP1MEN1KMT2A
SCHEMBL1187043 0.73 CYP2A6 (0.53) CYP2A6CHRNA7SMN1; SMN2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120291159-A1 Azoline Compounds for Combating Invertebrate Pests BASF SE (DE) 2012-11-15 US disclosed
WO-2011073444-A2 AZOLINE COMPOUNDS FOR COMBATING INVERTEBRATE PESTS BASF SE (DE) 2011-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120291159-A1 Azoline Compounds for Combating Invertebrate Pests CRY1, PIR, DDT CYP2A6 1529/4885CHRNA7 1709/4885SMN1; SMN2 2645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.